Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,213 | 79 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $955.54 | 9 | $0 (2020) |
| ABBVIE INC. | $605.18 | 16 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $575.37 | 10 | $0 (2018) |
| Neos Therapeutics, LP | $200.39 | 2 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $170.30 | 5 | $0 (2019) |
| Tris Pharma Inc | $159.94 | 8 | $0 (2017) |
| Shire North American Group Inc | $156.32 | 10 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $107.13 | 2 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $65.67 | 7 | $0 (2019) |
| Harmony Biosciences LLC | $56.28 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $143.41 | 5 | ABBVIE INC. ($143.41) |
| 2023 | $518.05 | 13 | AbbVie Inc. ($461.77) |
| 2020 | $38.11 | 2 | Sunovion Pharmaceuticals Inc. ($19.44) |
| 2019 | $640.75 | 17 | Sunovion Pharmaceuticals Inc. ($354.43) |
| 2018 | $579.15 | 9 | Sunovion Pharmaceuticals Inc. ($345.25) |
| 2017 | $1,294 | 33 | Otsuka America Pharmaceutical, Inc. ($432.12) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.73 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.22 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.30 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $30.06 | General |
| Category: SLEEP MEDICINE | ||||||
| 11/01/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $26.22 | General |
| Category: SLEEP MEDICINE | ||||||
| 10/10/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/06/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.52 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $123.68 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2020 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $18.67 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 01/15/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: CNS | ||||||
| 12/19/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $0.72 | General |
| Category: Central Nervous System (CNS) | ||||||
| 12/18/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: Central Nervous System (CNS) | ||||||
| 10/16/2019 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $32.14 | General |
| Category: Schizophrenia | ||||||
| 09/13/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Vyvanse (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Central Nervous System (CNS) | ||||||
| 08/28/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Neuroscience | ||||||
About Dr. Arsalan Darmal, MD
Dr. Arsalan Darmal, MD is a Psychiatry healthcare provider based in Newport Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164592465.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arsalan Darmal, MD has received a total of $3,213 in payments from pharmaceutical and medical device companies, with $143.41 received in 2024. These payments were reported across 79 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($3,213).
Practice Information
- Specialty Psychiatry
- Location Newport Beach, CA
- Active Since 11/08/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1164592465
Products in Payments
- LATUDA (Drug) $955.54
- VRAYLAR (Drug) $605.18
- REXULTI (Drug) $575.37
- Adzenys XR-ODT (Drug) $200.39
- SPRAVATO (Drug) $170.30
- Dyanavel XR (Drug) $159.94
- MYDAYIS (Drug) $123.82
- BELSOMRA (Drug) $107.13
- Trintellix (Drug) $68.76
- WAKIX (Drug) $56.28
- QUILLICHEW ER (Drug) $47.26
- VYVANSE (Drug) $32.50
- Fanapt (Drug) $32.14
- Vyvanse (Drug) $23.06
- APLENZIN (Drug) $18.74
- ADHANSIA XR (Drug) $18.67
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $18.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Newport Beach
Dr. Nader Oskooilar, Md, MD
Psychiatry — Payments: $321,179
Dr. Hadi Estakhri, M.d, M.D
Psychiatry — Payments: $16,721
Dr. Venice Sanchez, M.d, M.D
Psychiatry — Payments: $16,294
Dr. Hisham Korraa, M.d, M.D
Psychiatry — Payments: $14,252
Dr. Stefani Lafrenierre, Md, MD
Psychiatry — Payments: $7,842
Nimisha Jain, Pa, PA
Psychiatry — Payments: $6,289